07:01:12 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-12-17 Årsstämma
2024-11-14 Bokslutskommuniké 2024
2024-08-15 Kvartalsrapport 2024-Q3
2024-07-31 Extra Bolagsstämma 2024
2024-05-30 Årsstämma
2024-05-17 Kvartalsrapport 2024-Q2
2024-03-01 X-dag ordinarie utdelning CSMED 0.00 DKK
2024-02-14 Bokslutskommuniké 2023
2024-02-14 Kvartalsrapport 2024-Q1
2023-12-15 X-dag ordinarie utdelning CSMED 0.00 DKK
2023-07-18 Kvartalsrapport 2023-Q3
2023-05-17 Kvartalsrapport 2023-Q2
2023-04-14 Extra Bolagsstämma 2023
2023-02-17 Kvartalsrapport 2023-Q1
2023-02-14 Årsstämma
2023-02-10 X-dag ordinarie utdelning CSMED 0.00 DKK
2022-11-18 Bokslutskommuniké 2022
2022-08-13 Kvartalsrapport 2022-Q3
2022-05-20 Kvartalsrapport 2022-Q2
2022-02-18 Kvartalsrapport 2022-Q1
2021-12-10 X-dag ordinarie utdelning CSMED 0.00 DKK
2021-12-09 Årsstämma
2021-11-18 Bokslutskommuniké 2021

Beskrivning

LandDanmark
ListaSpotlight DK
SektorHälsovård
IndustriLäkemedel & Handel
CS Medica är ett danskt medicintekniskt bolag, dedikerat till läkemedelsforskning, utveckling, tillverkning och global kommersialisering. Bolaget blandar vetenskap och natur för att förbättra patienters liv med cannabinoidterapier för smärtlindring, och för att hantera autoimmuna och stressrelaterade symtom. Globalt erbjuder CS Medica CBD-behandlingar över disk (OTC), inklusive patenterade medicinska produkter, MHRA och MDR-registrerade artiklar, under varumärket CANNASEN® eller med egen märkning.
2022-08-26 08:00:00

Tuesday, 30 August 2022, is the last day of trading in CS MEDICA A/S's ("CS MEDICA" or the "Company") warrants of series TO 1 on Spotlight Stock Market. The warrants were issued in connection with the Company's issue of units that took place in September 2021. Each (1) warrant of series TO 1 entitles the holder to subscribe for one (1) new share in CS MEDICA. Last day to exercise the warrants of series TO 1 and subscribe for shares is 1 September 2022. Note that the banks/nominees need to be notified well in advance before the exercise period ends.

Each (1) warrant of series TO 1 entitles the holder to subscribe for one (1) new share in CS MEDICA at a price of DKK 9.30 per share. Warrants of series TO 1 that have not been exercised by Thursday, 1 September 2022, or sold by Tuesday, 30 August 2022, will expire and become worthless. Holders of warrants of series TO 1 need to act and instruct their respective bank/nominee in advance before the last day of the exercise period. Note that the banks/nominees need to be notified well in advance before the exercise period ends.
An information document and subscription forms are available on the websites of CS MEDICA (www.cs-medica.com), Sedermera Corporate Finance AB (www.sedermera.se) and Nordic Issuing AB (www.nordic-issuing.se).
Advisors and issuing agent
Sedermera Corporate Finance AB is the financial advisor and Markets & Corporate Law Nordic AB is the legal advisor to CS MEDICA in connection with the warrant exercise. Nordic Issuing AB is the issuing agent.

For further information about the warrant exercise, please contact:
Sedermera Corporate Finance AB
Phone: +46 40 - 615 14 10
E-mail: cf@sedermera.se
www.sedermera.se

Nordic Issuing AB
Phone: +46 (0)40-632 00 20
E-mail: info@nordic-issuing.se
www.nordic-issuing.se